Phase II study of induction therapy with gemcitabine and nab-paclitaxel followed by consolidation with mFOLFIRINOX in patients with metastatic pancreatic cancer.

Authors

null

Ramesh K. Ramanathan

Translational Genomics Research Institute - Virginia G Piper Cancer Center, Scottsdale, AZ

Ramesh K. Ramanathan , Peter Lee , John E. Seng , Stephen Patrick Anthony , Peter J. Rosen , Raul R. Mena , Vincent J. Picozzi , Jasgit C. Sachdev , Tim Larson , Ronald Korn , Gayle S. Jameson , Amy C. Stoll , Daniel D. Von Hoff , Joseph W. Leach

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01488552

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 224)

DOI

10.1200/jco.2014.32.3_suppl.224

Abstract #

224

Poster Bd #

A53

Abstract Disclosures

Similar Posters

First Author: Elisa Giommoni

First Author: Gabriela Dieguez